Cynata Therapeutics Limited ABN – 98 104 037 372 Level 3, 100 Cubitt Street Cremorne VIC 3121 Australia T: +613 7067 6940 E: [email protected] www.cynata.com ASX ANNOUNCEMENT 30 September 2026 Date of AGM and Closing Date for Director Nominations Melbourne, Australia; 30 September 2026: Cynata...
Date of AGM and Closing Date for Director Nominations
Filed with ASX · · 1 page · English
Summary by 6ix AI
Cynata Therapeutics Limited has announced the date for its Annual General Meeting and the closing date for director nominations. The AGM is scheduled for a Wednesday in late November, and nominations for directors must be submitted by mid-October. This announcement is made in accordance with ASX Listing Rule requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- Appendix 4G
- Corporate Governance Statement
- Annual Report
- Notification under Listing Rule 4.3D
- Notification of cessation of securities - CYP
Later from Cynata Therapeutics
- R&D Tax Incentive Loan Facility Extension
- Cynata Receives R&D TI Refund & Repays R&D TI Loan
- Termination of At-the-Market Subscription Deed
- Entitlement Offer & Unmarketable Parcel Sale Facility
- Proposed issue of securities - CYP
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics